These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35685993)

  • 1. Genomic landscape of T-cell lymphoblastic lymphoma.
    Li Z; Song Y; Zhang M; Wei Y; Ruan H
    Chin J Cancer Res; 2022 Apr; 34(2):83-94. PubMed ID: 35685993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma.
    Salmerón-Villalobos J; Ramis-Zaldivar JE; Balagué O; Verdú-Amorós J; Celis V; Sábado C; Garrido M; Mato S; Uriz J; Ortega MJ; Gutierrez-Camino A; Sinnett D; Illarregi U; Carron M; Regueiro A; Galera A; Gonzalez-Farré B; Campo E; Garcia N; Colomer D; Astigarraga I; Andrés M; Llavador M; Martin-Guerrero I; Salaverria I
    Pediatr Blood Cancer; 2022 Nov; 69(11):e29926. PubMed ID: 36000950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic signatures and prognosis of advanced stage Chinese pediatric T cell lymphoblastic lymphoma by whole exome sequencing.
    Liu Q; Yu X; Wen J; Yin N; Liao X; Zou P; Guo Y; Song L; Xiao J
    Front Pediatr; 2023; 11():1224966. PubMed ID: 37664545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutations.
    Spinella JF; Cassart P; Richer C; Saillour V; Ouimet M; Langlois S; St-Onge P; Sontag T; Healy J; Minden MD; Sinnett D
    Oncotarget; 2016 Oct; 7(40):65485-65503. PubMed ID: 27602765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemia.
    Bontoux C; Simonin M; Garnier N; Lhermitte L; Touzart A; Andrieu G; Bruneau J; Lengliné E; Plesa A; Boissel N; Baruchel A; Bertrand Y; Molina TJ; Macintyre E; Asnafi V
    Mod Pathol; 2022 Sep; 35(9):1227-1235. PubMed ID: 35562412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma.
    Kroeze E; Iaccarino I; Kleisman MM; Mondal M; Beder T; Khouja M; Höppner MP; Scheijde-Vermeulen MA; Kester LA; Brüggemann M; Baldus CD; Cario G; Bladergroen RS; Garnier N; Attarbaschi A; Verdu-Amorós J; Sutton R; Macintyre E; Scholten K; Arias Padilla L; Burkhardt B; Beishuizen A; den Boer ML; Kuiper RP; Loeffen JLC; Boer JM; Klapper W
    Blood; 2024 Jul; 144(1):74-83. PubMed ID: 38588489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma.
    Callens C; Baleydier F; Lengline E; Ben Abdelali R; Petit A; Villarese P; Cieslak A; Minard-Colin V; Rullier A; Moreau A; Baruchel A; Schmitt C; Asnafi V; Bertrand Y; Macintyre E
    J Clin Oncol; 2012 Jun; 30(16):1966-73. PubMed ID: 22547598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma.
    Huang YH; Wan CL; Dai HP; Xue SL
    Ann Hematol; 2023 Aug; 102(8):2001-2013. PubMed ID: 37227492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative genomic analysis of pediatric T-cell lymphoblastic lymphoma reveals candidates of clinical significance.
    Khanam T; Sandmann S; Seggewiss J; Ruether C; Zimmermann M; Norvil AB; Bartenhagen C; Randau G; Mueller S; Herbrueggen H; Hoffmann P; Herms S; Wei L; Woeste M; Wuensch C; Gowher H; Oschlies I; Klapper W; Woessmann W; Dugas M; Burkhardt B
    Blood; 2021 Apr; 137(17):2347-2359. PubMed ID: 33152759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of tofacitinib to achieve an objective response in a
    Wong J; Wall M; Corboy GP; Taubenheim N; Gregory GP; Opat S; Shortt J
    Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32843425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of a targeted next-generation DNA sequencing panel for pediatric T-cell lymphoblastic lymphoma to unravel biology and optimize treatment.
    Ruether C; Wuensch C; Randau G; Michgehl U; Trautmann M; Hartmann W; Sandmann S; Dugas M; Khanam T; Burkhardt B
    Genes Chromosomes Cancer; 2022 Aug; 61(8):459-470. PubMed ID: 35278000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
    Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
    Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-existence of
    Li M; Xiao L; Xu J; Zhang R; Guo J; Olson J; Wu Y; Li J; Song C; Ge Z
    Oncol Lett; 2016 Jul; 12(1):16-22. PubMed ID: 27347093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive view on genetic features, therapeutic modalities and prognostic models in adult T-cell lymphoblastic lymphoma.
    Zou Q; Ma S; Tian X; Cai Q
    Blood Sci; 2022 Jul; 4(3):155-160. PubMed ID: 36518593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia.
    Vicente C; Schwab C; Broux M; Geerdens E; Degryse S; Demeyer S; Lahortiga I; Elliott A; Chilton L; La Starza R; Mecucci C; Vandenberghe P; Goulden N; Vora A; Moorman AV; Soulier J; Harrison CJ; Clappier E; Cools J
    Haematologica; 2015 Oct; 100(10):1301-10. PubMed ID: 26206799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell lymphoblastic lymphoma shows differences and similarities with T-cell acute lymphoblastic leukemia by genomic and gene expression analyses.
    Basso K; Mussolin L; Lettieri A; Brahmachary M; Lim WK; Califano A; Basso G; Biondi A; Cazzaniga G; Rosolen A
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1063-75. PubMed ID: 21987448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of JAK2 mutations to T-cell lymphoblastic lymphoma development.
    Roncero AM; López-Nieva P; Cobos-Fernández MA; Villa-Morales M; González-Sánchez L; López-Lorenzo JL; Llamas P; Ayuso C; Rodríguez-Pinilla SM; Arriba MC; Piris MA; Fernández-Navarro P; Fernández AF; Fraga MF; Santos J; Fernández-Piqueras J
    Leukemia; 2016 Jan; 30(1):94-103. PubMed ID: 26216197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PHF6 and JAK3 mutations cooperate to drive T-cell acute lymphoblastic leukemia progression.
    Yuan S; Wang X; Hou S; Guo T; Lan Y; Yang S; Zhao F; Gao J; Wang Y; Chu Y; Shi J; Cheng T; Yuan W
    Leukemia; 2022 Feb; 36(2):370-382. PubMed ID: 34465864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.
    Li Y; Buijs-Gladdines JG; Canté-Barrett K; Stubbs AP; Vroegindeweij EM; Smits WK; van Marion R; Dinjens WN; Horstmann M; Kuiper RP; Buijsman RC; Zaman GJ; van der Spek PJ; Pieters R; Meijerink JP
    PLoS Med; 2016 Dec; 13(12):e1002200. PubMed ID: 27997540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.